Improvement of HbA1c and LDL-C by Imeglimin (Twymeeg) in the Diabetic Female Elderly Continue ReadingImprovement of HbA1c and LDL-C by Imeglimin (Twymeeg) in the Diabetic Female Elderly
Clinically Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) with Related Factors Continue ReadingClinically Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) with Related Factors
Recent Research Development of Imeglimin as Oral Hypoglycemic Agent (OHA) Continue ReadingRecent Research Development of Imeglimin as Oral Hypoglycemic Agent (OHA)
Detail Measurement of Pre-Prandial and Post-Prandial Blood Glucose during Imeglimin (Twymeeg) Treatment Continue ReadingDetail Measurement of Pre-Prandial and Post-Prandial Blood Glucose during Imeglimin (Twymeeg) Treatment
